RGP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.864200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.040400E-01
Normal-vs-Stage2
5.128000E-01
Normal-vs-Stage3
1.063800E-01
Normal-vs-Stage4
4.341000E-01
Stage1-vs-Stage2
7.887400E-01
Stage1-vs-Stage3
3.133900E-02
Stage1-vs-Stage4
4.802800E-01
Stage2-vs-Stage3
2.611700E-02
Stage2-vs-Stage4
5.062200E-01
Stage3-vs-Stage4
3.236400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.513600E-01
Normal-vs-AfricanAmerican
5.334000E-01
Normal-vs-Asian
3.411000E-01
Caucasian-vs-AfricanAmerican
9.549000E-01
Caucasian-vs-Asian
6.110200E-02
AfricanAmerican-vs-Asian
5.623500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.207000E-01
Normal-vs-Female
9.123000E-01
Male-vs-Female
4.469000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.499000E-01
Normal-vs-Age(41-60Yrs)
2.552600E-01
Normal-vs-Age(61-80Yrs)
8.674800E-01
Normal-vs-Age(81-100Yrs)
9.832000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.123400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.766800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.365200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.050200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.500600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.989400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.518800E-01
Normal-vs-Daily Drinker
4.190800E-01
Normal-vs-Weekly Drinker
5.567600E-01
Normal-vs-Occasional Drinker
6.671000E-01
Normal-vs-Social Drinker
5.023200E-01
Non Drinker-vs-Daily Drinker
3.644000E-01
Non Drinker-vs-Weekly Drinker
9.484000E-01
Non Drinker-vs-Occasional Drinker
4.228000E-02
Non Drinker-vs-Social Drinker
3.666300E-02
Daily Drinker-vs-Weekly Drinker
3.676600E-01
Daily Drinker-vs-Occasional Drinker
4.647000E-01
Daily Drinker-vs-Social Drinker
5.263000E-01
Weekly Drinker-vs-Occasional Drinker
9.650200E-02
Weekly Drinker-vs-Social Drinker
4.866300E-02
Occasional Drinker-vs-Social Drinker
4.622800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.904600E-01
Normal-vs-Grade 2
8.297700E-02
Normal-vs-Grade 3
6.772800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.876000E-01
Grade 1-vs-Grade 3
2.401200E-01
Grade 1-vs-Grade 4
1.904600E-01
Grade 2-vs-Grade 3
2.178000E-01
Grade 2-vs-Grade 4
8.297700E-02
Grade 3-vs-Grade 4
6.772800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.979600E-01
Normal-vs-NonDiabetic
5.287000E-01
Diabetic-vs-NonDiabetic
4.770000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.469200E-01
Normal-vs-NoPancreatitis
4.974600E-01
Pancreatitis-vs-NoPancreatitis
3.485400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.275000E-01
Normal-vs-N1
4.844800E-01
N0-vs-N1
6.911600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.722800E-01
Normal-vs-TP53-NonMutant
7.567800E-01
TP53-Mutant-vs-TP53-NonMutant
8.261600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
